Table 1.
Baseline Characteristics of the Study Cohort (n = 44)
| Baseline Characteristic | Total |
|---|---|
| Patient age at admission, median (IQR), y | 12.2 (4.9, 16.5) |
| Sex, n (%) | |
| Male | 20 (45.4) |
| Female | 24 (54.6) |
| Admitting diagnoses, n (%)a | |
| Cough | 8 (18.2) |
| Fever | 6 (13.6) |
| Hypoxia | 10 (22.7) |
| Pneumonia | 11 (25.0) |
| Respiratory distress | 14 (31.8) |
| Tachypnea | 1 (2.3) |
| Cystic fibrosis/exacerbation | 14 (31.8) |
| Tracheitis | 6 (13.6) |
| Other | 30 (68.2) |
| Chronic diagnoses, n (%)a | |
| Respiratory diagnoses | |
| Other respiratoryb | 17 (38.6) |
| Cystic fibrosis | 14 (31.8) |
| Tracheostomy dependence | 14 (31.8) |
| Neurologic diagnoses c | 11 (75.0) |
| Cardiac diagnoses d | 4 (9.1) |
| Gastrointestinal diagnoses e | 38 (86.4) |
| Immunosuppressed f | 3 (6.8) |
| Renal diagnoses | 2 (4.6) |
| Hepatic diagnoses | 3 (6.8) |
a Patients could have had multiple admitting or chronic diagnoses.
b Asthma, bronchopulmonary dysplasia (BPD), chronic lung disease (CLD), home respiratory support.
c Cerebral palsy, developmental delay, hydrocephalus, intellectual disability, nonambulatory, and/or ventriculoperitoneal shunt.
d Congenital heart disease, pulmonary hypertension.
e Aspiration, feeding-tube dependency, gastric fundoplication, supplemental nutrition requirement.
f Immunosuppressed due to medication, genetic, or both medication and genetic.